Search research articles
Contact Us
Filters
Showing results (41-50 of 151) with videos related to
Page
of 16
Sort By:
British Journal of Pharmacology
|
November 1, 1978
Effect of a phosphodiesterase inhibitor on cyclic GMP changes induced by muscarinic agonists in mouse neuroblastoma cells [proceedings]
P G Strange, T Bennett
Journal of Neurochemistry
|
December 1, 1984
Use of [3H]triphenylmethylphosphonium cation for estimating membrane potential in neuroblastoma cells
G Milligan, P G Strange
European Journal of Pharmacology
|
July 22, 1983
Apparent down-regulation of muscarinic acetylcholine receptors of neuroblastoma cells by pilocarpine is due to occluded agonist
G Milligan, P G Strange
Progress in Brain Research
|
January 1, 1982
The use of biochemical methods for estimating membrane potential
G Milligan, P G Strange
Journal of Neurochemistry
|
June 1, 1999
Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors
N Sartania, P G Strange
FEBS Letters
|
January 10, 1983
Characterisation of brain D2 dopamine receptors solubilised by lysophosphatidylcholine
M Wheatley, P G Strange
FEBS Letters
|
January 30, 1984
Reconstitution of solubilised brain D2 dopamine receptors into phospholipid vesicles
M Wheatley, P G Strange
Journal of Neurochemistry
|
July 1, 1984
Muscarinic acetylcholine receptors in neuroblastoma cells: lack of effect of Veratrum alkaloids on receptor number
G Milligan, P G Strange
Journal of Neurochemistry
|
August 11, 2000
Site-directed mutations in the third intracellular loop of the serotonin 5-HT(1A) receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner
A Malmberg, P G Strange
Biochemical Society Transactions
|
February 1, 1995
Pharmacological characterisation of high affinity [35S]GTP gamma S binding in membranes from CHO-K1 cells stably expressing rat D2(short) dopamine receptors
B Gardner, P G Strange
Page
of 16
Search research articles
Search
Showing results (41-50 of 151) with videos related to
Sort By:
Page
of 16
British Journal of Pharmacology
|
November 1, 1978
Effect of a phosphodiesterase inhibitor on cyclic GMP changes induced by muscarinic agonists in mouse neuroblastoma cells [proceedings]
P G Strange, T Bennett
Journal of Neurochemistry
|
December 1, 1984
Use of [3H]triphenylmethylphosphonium cation for estimating membrane potential in neuroblastoma cells
G Milligan, P G Strange
European Journal of Pharmacology
|
July 22, 1983
Apparent down-regulation of muscarinic acetylcholine receptors of neuroblastoma cells by pilocarpine is due to occluded agonist
G Milligan, P G Strange
Progress in Brain Research
|
January 1, 1982
The use of biochemical methods for estimating membrane potential
G Milligan, P G Strange
Journal of Neurochemistry
|
June 1, 1999
Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors
N Sartania, P G Strange
FEBS Letters
|
January 10, 1983
Characterisation of brain D2 dopamine receptors solubilised by lysophosphatidylcholine
M Wheatley, P G Strange
FEBS Letters
|
January 30, 1984
Reconstitution of solubilised brain D2 dopamine receptors into phospholipid vesicles
M Wheatley, P G Strange
Journal of Neurochemistry
|
July 1, 1984
Muscarinic acetylcholine receptors in neuroblastoma cells: lack of effect of Veratrum alkaloids on receptor number
G Milligan, P G Strange
Journal of Neurochemistry
|
August 11, 2000
Site-directed mutations in the third intracellular loop of the serotonin 5-HT(1A) receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner
A Malmberg, P G Strange
Biochemical Society Transactions
|
February 1, 1995
Pharmacological characterisation of high affinity [35S]GTP gamma S binding in membranes from CHO-K1 cells stably expressing rat D2(short) dopamine receptors
B Gardner, P G Strange
Page
of 16